Hikma Pharmaceuticals PLC (LON: HIK)

Hikma Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	236	205	270	426	323	442
Trading Asset Securities	24	24	22	24	24	23
Cash & Short-Term Investments	260	229	292	450	347	465
Cash Growth	-11.56%	-21.58%	-35.11%	29.68%	-25.38%	56.57%
Accounts Receivable	937	789	777	781	662	637
Other Receivables	28	84	64	95	74	110
Receivables	965	873	841	876	736	747
Inventory	936	891	776	695	757	568
Prepaid Expenses	81	72	74	65	56	49
Restricted Cash	-	-	-	-	4	1
Other Current Assets	43	35	16	8	22	18
Total Current Assets	2,285	2,100	1,999	2,094	1,922	1,848
Property, Plant & Equipment	1,137	1,141	1,081	1,146	1,068	962
Long-Term Investments	63	65	52	46	34	29
Goodwill	383	388	389	285	289	282
Other Intangible Assets	711	712	735	607	587	552
Long-Term Deferred Tax Assets	235	226	192	183	221	243
Other Long-Term Assets	33	48	23	11	14	14
Total Assets	4,847	4,680	4,471	4,372	4,135	3,930
Accounts Payable	541	309	291	262	279	286
Accrued Expenses	138	388	272	305	277	257
Short-Term Debt	79	46	75	64	117	60
Current Portion of Long-Term Debt	127	104	64	48	41	509
Current Portion of Leases	9	11	9	9	10	9
Current Income Taxes Payable	84	74	73	57	72	82
Current Unearned Revenue	182	179	193	213	162	142
Other Current Liabilities	220	228	100	58	70	126
Total Current Liabilities	1,380	1,339	1,077	1,016	1,028	1,471
Long-Term Debt	1,017	975	1,074	651	692	48
Long-Term Leases	44	55	61	74	72	59
Long-Term Deferred Tax Liabilities	26	25	19	24	31	20
Other Long-Term Liabilities	80	77	92	140	164	203
Total Liabilities	2,547	2,471	2,323	1,905	1,987	1,801
Common Stock	40	40	40	42	41	41
Additional Paid-In Capital	282	282	282	282	282	282
Retained Earnings	2,287	2,158	2,092	2,189	1,892	1,973
Treasury Stock	-	-	-	-	-	-1
Comprehensive Income & Other	-323	-282	-279	-60	-80	-178
Total Common Equity	2,286	2,198	2,135	2,453	2,135	2,117
Minority Interest	14	11	13	14	13	12
Shareholders' Equity	2,300	2,209	2,148	2,467	2,148	2,129
Total Liabilities & Equity	4,847	4,680	4,471	4,372	4,135	3,930
Total Debt	1,276	1,191	1,283	846	932	685
Net Cash (Debt)	-1,016	-962	-991	-396	-585	-220
Net Cash Per Share	-4.55	-4.33	-4.41	-1.70	-2.46	-0.91
Filing Date Shares Outstanding	221.75	221.08	220.24	231.5	230.46	242.28
Total Common Shares Outstanding	221.75	221.08	220.24	231.5	230.46	242.28
Working Capital	905	761	922	1,078	894	377
Book Value Per Share	10.31	9.94	9.69	10.60	9.26	8.74
Tangible Book Value	1,192	1,098	1,011	1,561	1,259	1,283
Tangible Book Value Per Share	5.38	4.97	4.59	6.74	5.46	5.30
Land	-	797	725	676	636	597
Machinery	-	1,042	964	934	891	810
Construction In Progress	-	272	262	271	255	233

Source: S&P Capital IQ. Standard template. Financial Sources.